Precision Medicine Group · 1 month ago
Medical Editor - Market Access Marketing
United States
Full-time
Remote
Mid Level
$54K/yr - $82K/yr
3+ years expPrecision Medicine Group is a leading payer marketing agency that supports global pharmaceutical and life sciences clients in achieving commercial excellence. The Medical Editor will review and edit content for accuracy and adherence to style guidelines, ensuring editorial integrity throughout the content development process.
BiotechnologyHealth Care
Responsibilities
Reviewing and editing content for correct spelling, grammar, and sentence structure
Ensuring fulfillment of creative brief and adherence to AMA and client style
Fact checking materials and aligning with writers on annotating and referencing
Representing Editorial at internal start-up and status meetings
Working with the extended team to facilitate project completion
Ensuring all pieces are aligned with each client’s MLR submission process and supporting the MLR process
Qualification
Required
Bachelor's degree in English, Journalism, or similar field
3+ years of editing experience in healthcare and/or pharmaceutical industry required
Thorough knowledge of AMA (11th edition) style
Proficiency with Microsoft Office suite of products as well as familiarity with editing in Adobe Acrobat Professional
Preferred
At least 1 year of experience in the advertising and/or pharmaceutical marketing industry preferred
Industry experience to include in advertising, pharmaceutical marketing, medical communications, and/or medical education industry
Familiarity with Veeva, Zinc, or MLR reviews and submissions systems
Knowledge of FDA requirements with respect to pharmaceutical advertising
Benefits
Discretionary annual bonus
Health insurance
Retirement savings benefits
Life insurance
Disability benefits
Parental leave
Paid time off for sick leave and vacation
Company
Precision Medicine Group
We founded Precision Medicine Group in 2012 because we believed there was a transformational opportunity to improve the process of bringing new drugs to market.
1001-5000 employees
Funding
Current Stage
Late StageLeadership Team
Mark Clein
Co-Founder & Chief Executive Officer
Matt DeZee
Chief Financial Officer
Company data provided by crunchbase